This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4azp
From Proteopedia
(Difference between revisions)
| (5 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | {{STRUCTURE_4azp| PDB=4azp | SCENE= }} | ||
| - | ===Murine epidermal fatty acid-binding protein (FABP5) in complex with the endocannabinoid anandamide=== | ||
| - | == | + | ==Murine epidermal fatty acid-binding protein (FABP5) in complex with the endocannabinoid anandamide== |
| - | [[4azp]] is a 1 chain structure with sequence from [ | + | <StructureSection load='4azp' size='340' side='right'caption='[[4azp]], [[Resolution|resolution]] 2.10Å' scene=''> |
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[4azp]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4AZP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4AZP FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.1Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A9M:N-(2-HYDROXYETHYL)ICOSANAMIDE'>A9M</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4azp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4azp OCA], [https://pdbe.org/4azp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4azp RCSB], [https://www.ebi.ac.uk/pdbsum/4azp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4azp ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/FABP5_MOUSE FABP5_MOUSE] High specificity for fatty acids. Highest affinity for C18 chain length (By similarity). | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | In addition to binding intracellular fatty acids, fatty-acid-binding proteins (FABPs) have recently been reported to also transport the endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG), arachidonic acid derivatives that function as neurotransmitters and mediate a diverse set of physiological and psychological processes. To understand how the endocannabinoids bind to FABPs, the crystal structures of FABP5 in complex with AEA, 2-AG and the inhibitor BMS-309403 were determined. These ligands are shown to interact primarily with the substrate-binding pocket via hydrophobic interactions as well as a common hydrogen bond to the Tyr131 residue. This work advances our understanding of FABP5-endocannabinoid interactions and may be useful for future efforts in the development of small-molecule inhibitors to raise endocannabinoid levels. | ||
| + | |||
| + | Crystallographic study of FABP5 as an intracellular endocannabinoid transporter.,Sanson B, Wang T, Sun J, Wang L, Kaczocha M, Ojima I, Deutsch D, Li H Acta Crystallogr D Biol Crystallogr. 2014 Feb;70(Pt 2):290-8. doi:, 10.1107/S1399004713026795. Epub 2014 Jan 29. PMID:24531463<ref>PMID:24531463</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 4azp" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Fatty acid-binding protein 3D structures|Fatty acid-binding protein 3D structures]] | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
| - | [[Category: Deutsch | + | [[Category: Deutsch D]] |
| - | [[Category: Kaczocha | + | [[Category: Kaczocha M]] |
| - | [[Category: Li | + | [[Category: Li H]] |
| - | [[Category: Ojima | + | [[Category: Ojima I]] |
| - | [[Category: Sanson | + | [[Category: Sanson B]] |
| - | [[Category: Sun | + | [[Category: Sun J]] |
| - | [[Category: Wang | + | [[Category: Wang T]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Murine epidermal fatty acid-binding protein (FABP5) in complex with the endocannabinoid anandamide
| |||||||||||
Categories: Large Structures | Mus musculus | Deutsch D | Kaczocha M | Li H | Ojima I | Sanson B | Sun J | Wang T
